Enabling Pharmaceutical Innovation Through Nanotechnology
B2B platform providing proprietary drug delivery technologies for pharmaceutical licensing. Three validated nanotechnology platforms ready for commercial partnership.
Core Technology Platforms
Three Proprietary Nanotechnology Platforms
Each platform addresses a critical pharmaceutical delivery challenge with validated, scalable solutions ready for commercial licensing.
Why AGCP
Your Drug Delivery Technology Partner
Pharmaceutical companies choose AGCP as their nanotechnology platform partner for our proven technology, regulatory expertise, and cost-effective manufacturing capabilities.
B2B Platform Model
We enable your products. License our proprietary nanotechnology platforms to enhance your drug delivery systems without building from scratch.
Regulatory Expertise
Deep regulatory knowledge to navigate commercialization pathways across global markets.
Proven Stability
Extensive validation data including 18+ months nanoemulsion stability and 4+ years CBD formulation data demonstrating commercial viability.
Cost-Effective Scale
Proprietary manufacturing processes delivering pharmaceutical-grade output at a fraction of conventional costs, enabling competitive product development.
Validated Performance Metrics
Our technology platforms are backed by extensive validation data and pharmaceutical-grade manufacturing standards.
18+
Months Stability Data
Validated nanoemulsion formulation stability
<10nm
Particle Achievement
Nano-suspension particle size for BBB penetration
95%+
Cost Reduction
Graphene production cost versus market pricing
Ready to Enhance Your Drug Delivery Pipeline?
Discover how AGCP's nanotechnology platforms can accelerate your pharmaceutical development. We welcome partnership, licensing, and investment inquiries.